Importantly, our findings reveal that a TLR–TRIF–RIPK3–caspase-8 signalling pathway may promote K/B × N arthritis disease persistence by driving IL-1β production via transcriptional induction, and/or cleavage induced activation. Here, RIPK3 is linked to arthritic joint disease.